1998
DOI: 10.1016/s0003-4975(97)01427-6
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Treatment of Bronchopleural Fistulas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
69
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 109 publications
(72 citation statements)
references
References 12 publications
3
69
0
Order By: Relevance
“…BPF is an infrequent but potentially life-threatening complication in lung surgery, with incidences from 1.3% A B to 34.3% and mortalities from 0.7% to 67% (1)(2)(3)(4)(5)7,9). Various risk factors as neoadjuvant therapy and closure of bronchial stump, had been reported (1,(10)(11)(12).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…BPF is an infrequent but potentially life-threatening complication in lung surgery, with incidences from 1.3% A B to 34.3% and mortalities from 0.7% to 67% (1)(2)(3)(4)(5)7,9). Various risk factors as neoadjuvant therapy and closure of bronchial stump, had been reported (1,(10)(11)(12).…”
Section: Discussionmentioning
confidence: 99%
“…Chest cavity cleanup using antibiotics or disinfectants was considered in the second step to create an aseptic residual chest cavity. However, all these maneuvers were associated with certain failure rate (5,7).…”
Section: Original Articlementioning
confidence: 99%
“…Varoli et al in 1998 [14] published their study describing another method in closing central BPF. They successfully treated 23 out of 35 consecutive patients with central postresectional BPF with multiple and repeatedly submucosal injections of polidocanol -hydroxypolyethoxidodecane (Aethoxysklerol Kreussler) on the margins of the fistula.…”
Section: Bronchoscopic Treatment Of Bronchopleural Fistulamentioning
confidence: 99%
“…Recently, endoscopic injections of polidocanol, a sclerosing agent, and ethanol have been successfully used to treat bronchopleural fistulas. A large case series by Varoli et al [64] provides the strongest evidence for treatment efficacy with this modality. In that series, polidocanol was used to treat bronchopleural fistulas that developed in 35 patients between 3 and 25 years post-operatively, although the majority occurred within 1 month.…”
Section: Therapeutic Applications Of Tbnimentioning
confidence: 99%